SHEA IDLEWINE: Open Payments
NPI 1427694983 · SHELBYVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,423 in 76 payments from 14 companies in 2025. Trend: 2023 $503 · 2024 $1,471 · 2025 $1,423
Food & beverage: $1,423
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $319 |
| Novartis Pharmaceuticals Corporation | 18 | $271 |
| AstraZeneca Pharmaceuticals LP | 13 | $218 |
| Merck Sharp & Dohme LLC | 8 | $135 |
| Corcept Therapeutics | 4 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $92 |
| Boston Scientific Corporation | 4 | $87 |
| PFIZER INC. | 4 | $60 |
| Madrigal Pharmaceuticals | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
Products named: LEQVIO, FARXIGA, Wegovy, Ozempic, Korlym, JARDIANCE, WATCHMAN FLX, VERQUVO.
Industry payments across IN — which companies pay providers there.
